173 related articles for article (PubMed ID: 30994217)
1. Normal and keloid fibroblasts are differentially influenced by IFN-γ and triamcinolone as well as by their combination.
Euler T; Valesky EM; Meissner M; Hrgovic I; Kaufmann R; Kippenberger S; Zöller NN
Wound Repair Regen; 2019 Sep; 27(5):450-461. PubMed ID: 30994217
[TBL] [Abstract][Full Text] [Related]
2. IFN-gamma fails to antagonize fibrotic effect of TGF-beta on keloid-derived dermal fibroblasts.
Hasegawa T; Nakao A; Sumiyoshi K; Tsuboi R; Ogawa H
J Dermatol Sci; 2003 Jun; 32(1):19-24. PubMed ID: 12788525
[TBL] [Abstract][Full Text] [Related]
3. Water-filtered near-infrared influences collagen synthesis of keloid-fibroblasts in contrast to normal foreskin fibroblasts.
Zöller N; König A; Butting M; Kaufmann R; Bernd A; Valesky E; Kippenberger S
J Photochem Photobiol B; 2016 Oct; 163():194-202. PubMed ID: 27588716
[TBL] [Abstract][Full Text] [Related]
4. A study of the combination of triamcinolone and 5-fluorouracil in modulating keloid fibroblasts in vitro.
Huang L; Cai YJ; Lung I; Leung BC; Burd A
J Plast Reconstr Aesthet Surg; 2013 Sep; 66(9):e251-9. PubMed ID: 23810214
[TBL] [Abstract][Full Text] [Related]
5. Superior effect of combination vs. single steroid therapy in keloid disease: a comparative in vitro analysis of glucocorticoids.
Syed F; Singh S; Bayat A
Wound Repair Regen; 2013; 21(1):88-102. PubMed ID: 23126666
[TBL] [Abstract][Full Text] [Related]
6. Major suppression of pro-alpha1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide.
Kauh YC; Rouda S; Mondragon G; Tokarek R; diLeonardo M; Tuan RS; Tan EM
J Am Acad Dermatol; 1997 Oct; 37(4):586-9. PubMed ID: 9344198
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
[TBL] [Abstract][Full Text] [Related]
8. Triamcinolone stimulates bFGF production and inhibits TGF-beta1 production by human dermal fibroblasts.
Carroll LA; Hanasono MM; Mikulec AA; Kita M; Koch RJ
Dermatol Surg; 2002 Aug; 28(8):704-9. PubMed ID: 12174062
[TBL] [Abstract][Full Text] [Related]
9. [Effects of interferon-gamma on the transforming growth factor beta/Smad pathway in keloid-derived fibroblasts].
Liu JQ; Hu DH; Zhang ZF; Guan H; She T; Zhang J; Bai XZ
Zhonghua Shao Shang Za Zhi; 2009 Dec; 25(6):454-9. PubMed ID: 20193171
[TBL] [Abstract][Full Text] [Related]
10. Improving the anti-keloid outcomes through liposomes loading paclitaxel-cholesterol complexes.
Wang M; Chen L; Huang W; Jin M; Wang Q; Gao Z; Jin Z
Int J Nanomedicine; 2019; 14():1385-1400. PubMed ID: 30863067
[TBL] [Abstract][Full Text] [Related]
11. Effect of camptothecin on collagen synthesis in fibroblasts from patients with keloid.
Zhang GY; Gao WY; Li X; Yi CG; Zheng Y; Li Y; Xiao B; Ma XJ; Yan L; Lu KH; Han Y; Guo SZ
Ann Plast Surg; 2009 Jul; 63(1):94-9. PubMed ID: 19546682
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGFbeta1.
Chipev CC; Simon M
BMC Dermatol; 2002 Nov; 2():13. PubMed ID: 12445328
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo.
Tredget EE; Wang R; Shen Q; Scott PG; Ghahary A
J Interferon Cytokine Res; 2000 Feb; 20(2):143-51. PubMed ID: 10714549
[TBL] [Abstract][Full Text] [Related]
16. p53 and apoptosis alterations in keloids and keloid fibroblasts.
Ladin DA; Hou Z; Patel D; McPhail M; Olson JC; Saed GM; Fivenson DP
Wound Repair Regen; 1998; 6(1):28-37. PubMed ID: 9776848
[TBL] [Abstract][Full Text] [Related]
17. mTOR as a potential therapeutic target for treatment of keloids and excessive scars.
Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT
Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482
[TBL] [Abstract][Full Text] [Related]
18. [Effect of tranilast, an anti-allergic drug, on the human keloid tissues].
Suzawa H; Kikuchi S; Ichikawa K; Arai N; Tazawa S; Tsuchiya O; Momose Y; Shibata N; Sugimoto C; Hamano S
Nihon Yakurigaku Zasshi; 1992 Apr; 99(4):231-9. PubMed ID: 1376711
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane suppresses cell growth and collagen expression of keloid fibroblasts.
Kawarazaki A; Horinaka M; Yasuda S; Numajiri T; Nishino K; Sakai T
Wound Repair Regen; 2017 Apr; 25(2):224-233. PubMed ID: 28120534
[TBL] [Abstract][Full Text] [Related]
20. Elevated interleukin-6 expression in keloid fibroblasts.
Xue H; McCauley RL; Zhang W
J Surg Res; 2000 Mar; 89(1):74-7. PubMed ID: 10720455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]